These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 25448108)

  • 61. Immunogenicity and protective capacity of Mycobacterium bovis BCG after oral or intragastric administration in mice.
    Lagranderie M; Chavarot P; Balazuc AM; Marchal G
    Vaccine; 2000 Jan; 18(13):1186-95. PubMed ID: 10649619
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Enhancement of the effect of BCG vaccine against tuberculosis using DDA/TDB liposomes containing a fusion protein of HspX, PPE44, and EsxV.
    Mansury D; Ghazvini K; Amel Jamehdar S; Badiee A; Tafaghodi M; Nikpoor AR; Amini Y; Jaafari MR
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):370-377. PubMed ID: 30691310
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Persistent BCG bacilli perpetuate CD4 T effector memory and optimal protection against tuberculosis.
    Kaveh DA; Garcia-Pelayo MC; Hogarth PJ
    Vaccine; 2014 Dec; 32(51):6911-6918. PubMed ID: 25444816
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Influence of Mycobacterium bovis BCG vaccination on cellular immune response of guinea pigs challenged with Mycobacterium tuberculosis.
    Ordway D; Henao-Tamayo M; Shanley C; Smith EE; Palanisamy G; Wang B; Basaraba RJ; Orme IM
    Clin Vaccine Immunol; 2008 Aug; 15(8):1248-58. PubMed ID: 18508930
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Lymphocyte recruitment and protective efficacy against pulmonary mycobacterial infection are independent of the route of prior Mycobacterium bovis BCG immunization.
    Palendira U; Bean AG; Feng CG; Britton WJ
    Infect Immun; 2002 Mar; 70(3):1410-6. PubMed ID: 11854227
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis.
    Poyntz HC; Stylianou E; Griffiths KL; Marsay L; Checkley AM; McShane H
    Tuberculosis (Edinb); 2014 May; 94(3):226-37. PubMed ID: 24572168
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Rapid immunity to vaccination with woodchuck hepatitis virus surface antigen using cationic liposome-DNA complexes as adjuvant.
    Cote PJ; Butler SD; George AL; Fairman J; Gerin JL; Tennant BC; Menne S
    J Med Virol; 2009 Oct; 81(10):1760-72. PubMed ID: 19697409
    [TBL] [Abstract][Full Text] [Related]  

  • 68. DNA vaccine combinations expressing either tissue plasminogen activator signal sequence fusion proteins or ubiquitin-conjugated antigens induce sustained protective immunity in a mouse model of pulmonary tuberculosis.
    Delogu G; Li A; Repique C; Collins F; Morris SL
    Infect Immun; 2002 Jan; 70(1):292-302. PubMed ID: 11748195
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Lactoferrin modulation of BCG-infected dendritic cell functions.
    Hwang SA; Actor JK
    Int Immunol; 2009 Oct; 21(10):1185-97. PubMed ID: 19692539
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A single dose of killed Mycobacterium bovis BCG in a novel class of adjuvant (Novasome) protects guinea pigs from lethal tuberculosis.
    Chambers MA; Wright DC; Brisker J; Williams A; Hatch G; Gavier-Widén D; Hall G; Marsh PD; Glyn Hewinson R
    Vaccine; 2004 Feb; 22(8):1063-71. PubMed ID: 15161084
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Mice fed lipid-encapsulated Mycobacterium bovis BCG are protected against aerosol challenge with Mycobacterium tuberculosis.
    Aldwell FE; Brandt L; Fitzpatrick C; Orme IM
    Infect Immun; 2005 Mar; 73(3):1903-5. PubMed ID: 15731098
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Single intranasal mucosal Mycobacterium bovis BCG vaccination confers improved protection compared to subcutaneous vaccination against pulmonary tuberculosis.
    Chen L; Wang J; Zganiacz A; Xing Z
    Infect Immun; 2004 Jan; 72(1):238-46. PubMed ID: 14688101
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Qualification of a whole blood intracellular cytokine staining assay to measure mycobacteria-specific CD4 and CD8 T cell immunity by flow cytometry.
    Kagina BM; Mansoor N; Kpamegan EP; Penn-Nicholson A; Nemes E; Smit E; Gelderbloem S; Soares AP; Abel B; Keyser A; Sidibana M; Hughes JE; Kaplan G; Hussey GD; Hanekom WA; Scriba TJ
    J Immunol Methods; 2015 Feb; 417():22-33. PubMed ID: 25523923
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Immunogenicity of orally-delivered lipid-formulated BCG vaccines and protection against Mycobacterium tuberculosis infection.
    Vipond J; Cross ML; Lambeth MR; Clark S; Aldwell FE; Williams A
    Microbes Infect; 2008; 10(14-15):1577-81. PubMed ID: 18848638
    [TBL] [Abstract][Full Text] [Related]  

  • 75. An essential role for endogenous interferon-gamma in the generation of protective T cells against Mycobacterium bovis BCG in mice.
    Yang J; Mitsuyama M
    Immunology; 1997 Aug; 91(4):529-35. PubMed ID: 9378490
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Enhancement of innate and cell-mediated immunity by antimycobacterial antibodies.
    de Vallière S; Abate G; Blazevic A; Heuertz RM; Hoft DF
    Infect Immun; 2005 Oct; 73(10):6711-20. PubMed ID: 16177348
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Synergistic effect of bacillus calmette guerin and a tuberculosis subunit vaccine in cationic liposomes: increased immunogenicity and protection.
    Dietrich J; Billeskov R; Doherty TM; Andersen P
    J Immunol; 2007 Mar; 178(6):3721-30. PubMed ID: 17339470
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Mycobacterium bovis BCG-mediated protection against W-Beijing strains of Mycobacterium tuberculosis is diminished concomitant with the emergence of regulatory T cells.
    Ordway DJ; Shang S; Henao-Tamayo M; Obregon-Henao A; Nold L; Caraway M; Shanley CA; Basaraba RJ; Duncan CG; Orme IM
    Clin Vaccine Immunol; 2011 Sep; 18(9):1527-35. PubMed ID: 21795460
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Immune reactions of CD4- and CD8-positive T cell subpopulations in spleen and lymph nodes of guinea pigs after vaccination with Bacillus Calmette Guerin.
    Klünner T; Bartels T; Vordermeier M; Burger R; Schäfer H
    Vaccine; 2001 Feb; 19(15-16):1968-77. PubMed ID: 11228367
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Reducing the activity and secretion of microbial antioxidants enhances the immunogenicity of BCG.
    Sadagopal S; Braunstein M; Hager CC; Wei J; Daniel AK; Bochan MR; Crozier I; Smith NE; Gates HO; Barnett L; Van Kaer L; Price JO; Blackwell TS; Kalams SA; Kernodle DS
    PLoS One; 2009; 4(5):e5531. PubMed ID: 19436730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.